Cancer BiologybioRxiv
Targeting effector pathways in RAC1P29S-driven malignant melanoma
C. Uribe-Alvarez, S. L. Guerrero-Rodriguez, J. Rhodes…·D. Araiza-Olivera
This study investigates the efficacy of targeting effector pathways of RAC1P29S in melanoma, showing that PAK and SRF/MRTF inhibitors reduce tumor growth in vitro and in zebrafish models.
DOI 10.1080/21541248.2020.1728469